Divisional Patents Remain Divisive In Europe
Legal Conference Hears Of Continuing ‘Pernicious Effects’ On Generic Entry And Access
Divisional patents remain a major barrier to market entry for generics in Europe, heard attendees to Medicines for Europe’s legal affairs conference in Dublin earlier this month.